Valneva SE ADR (VALN)

Valneva SE ADR (VALN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $527M; returns 1 day -1.9%, 1 week -6.2%, 1 year -45.7%.

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. The company's portfolio includes vaccines for Japanese encephalitis (IXIARO/JESPECT) and cholera/ETEC diarrhea (DUKORAL). Valneva's key product is IXCHIQ, a single-dose chikungunya vaccine.

Groups VALN belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Infectious Diseases
• Commercial Stage
• Commercial Stage Biotech
• Life Sciences
• R&D
• Unmet Medical Needs
• Clinical Stage

VALN financial model: income statement, cash flow and balance sheet